The Microarray 180K AFCVSCBPOCPB Test, available at DNA Labs UAE, is a sophisticated genetic test that utilizes a high-density microarray technology, capable of analyzing approximately 180,000 genetic markers. This comprehensive test is designed to detect a wide range of genetic abnormalities, including chromosomal imbalances and single nucleotide polymorphisms (SNPs), which can be linked to various genetic disorders and conditions. With a cost of 7020 AED, this test provides a detailed overview of an individual's genetic makeup, offering valuable insights for diagnostic, prognostic, and therapeutic purposes. DNA Labs UAE, known for its state-of-the-art facilities and expert staff, ensures accurate and reliable results, making the Microarray 180K AFCVSCBPOCPB Test a significant tool for individuals seeking in-depth genetic analysis.
The Pancreatic Mutation Panel Test, offered by DNA Labs UAE, is a sophisticated diagnostic tool designed to identify genetic mutations associated with pancreatic cancer. This comprehensive test screens for a range of genetic alterations that could indicate an individual's predisposition to developing pancreatic cancer or provide crucial information for the management of existing pancreatic conditions. With a cost of 5700 AED, the test represents an investment in personalized healthcare, enabling targeted treatment plans and informed decisions regarding patient care. By analyzing specific genetic markers, the Pancreatic Mutation Panel Test aids in early detection, prognosis assessment, and the selection of the most effective therapeutic strategies, ultimately contributing to improved patient outcomes in the management of pancreatic diseases.
The APO E Genotyping Test is a specialized diagnostic procedure designed to identify specific variations in the apolipoprotein E (APO E) gene. This gene plays a crucial role in lipid metabolism, influencing the body's ability to process fats and cholesterol. The test is particularly significant for assessing an individual's genetic predisposition to certain conditions, such as cardiovascular disease, Alzheimer's disease, and other forms of dementia, based on the presence of different APO E alleles (e2, e3, and e4).
Performed at DNA Labs UAE, a leading facility in genetic testing, the APO E Genotyping Test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The laboratory then analyzes the sample to determine the specific alleles of the APO E gene present in the individual's genome. This information can be invaluable for personalized medical guidance, including risk assessment, prevention strategies, and tailored treatment plans for conditions associated with APO E gene variations.
The cost of the APO E Genotyping Test at DNA Labs UAE is 5700 AED. While the price may seem high, the value of the insights gained from this test can be substantial, offering individuals a proactive approach to managing their health and wellness based on their unique genetic makeup.
The Oncopro Hereditary Cancer Risk Panel is a comprehensive genetic screening test available at DNA Labs UAE, designed to identify individuals at an increased risk of developing cancer due to inherited genetic mutations. This advanced test screens for mutations in 200 genes that are known to be associated with a wide range of hereditary cancers, providing a broad assessment of an individual's genetic predisposition to cancer.
By analyzing a person's DNA, the test can uncover genetic variations that may increase the risk of developing cancers such as breast, ovarian, colorectal, prostate, and many others. The information obtained from the Oncopro Hereditary Cancer Risk Panel can be pivotal for both individuals and their healthcare providers in making informed decisions about cancer surveillance, prevention strategies, and personalized treatment plans.
The test is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. The cost of the Oncopro Hereditary Cancer Risk Panel is 2400 AED, reflecting the comprehensive nature of the test and the valuable insights it offers into an individual's cancer risk profile. This test is a powerful tool for those with a family history of cancer or anyone interested in understanding their genetic cancer risk, ultimately empowering them with the knowledge to take proactive steps in managing their health.
The Paroxetine Test is a specialized diagnostic procedure aimed at monitoring and measuring the levels of paroxetine, a selective serotonin reuptake inhibitor (SSRI) used primarily in the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, and social anxiety disorder, among others. This test is crucial for healthcare providers to determine the appropriate dosage for patients, ensuring therapeutic efficacy while minimizing potential side effects. Conducted at DNA Labs UAE, a leading facility in genetic and biochemical testing, the test offers precise and reliable results. The cost for undergoing the Paroxetine Test at DNA Labs UAE is set at 6550 AED. This investment is pivotal for personalized medicine, allowing for tailored treatment plans that align closely with the patient's unique metabolic profile and health needs.
The Colorectal Cancer Panel NRASKRASBRAF Test is a specialized diagnostic tool designed to identify mutations in the NRAS, KRAS, and BRAF genes. These mutations are significant because they can play a crucial role in the development and progression of colorectal cancer. By analyzing these specific genes, the test helps in determining the molecular profile of the cancer, which is critical for tailoring the most effective treatment strategies for the patient.
Performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this test provides a comprehensive analysis crucial for guiding decisions regarding targeted therapy. Given the precision and specialized technology involved, the cost of the test is 6550 AED. This investment can be invaluable for patients with colorectal cancer, as it opens the door to personalized treatment plans that can significantly improve outcomes.
The "Solid Tumor Combo2 MSINRASKRASBRAFH RAS Test" is a comprehensive genomic profiling assay designed to identify specific mutations in solid tumors that can influence treatment decisions and patient outcomes. This test targets mutations in several key genes: MSI (Microsatellite Instability), NRAS (Neuroblastoma RAS Viral Oncogene Homolog), KRAS (Kirsten Rat Sarcoma Viral Oncogene Homolog), BRAF (B-Raf Proto-Oncogene), and other RAS gene family mutations. By detecting these mutations, the test helps in determining the suitability of targeted therapies for patients with various types of solid tumors, including colorectal cancer, melanoma, and lung cancer, among others.
Performed at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities, the test is conducted using cutting-edge sequencing technologies to ensure high accuracy and reliability of results. The cost of the test is set at 7200 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed.
This test represents a significant advancement in personalized medicine, offering hope for more effective and tailored treatment strategies for patients battling solid tumors. By pinpointing specific genetic mutations, healthcare providers can select therapies that are more likely to succeed, thereby improving the chances of a favorable outcome for the patient.
The Spinal Muscular Atrophy (SMA) Gene Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify mutations in genes associated with Spinal Muscular Atrophy, a genetic disorder characterized by weakness and wasting of the muscles. This condition is caused by the loss of specialized nerve cells, called motor neurons, in the spinal cord and the part of the brain that is connected to the spinal cord. The SMA Gene Panel Test looks specifically for mutations in the SMN1 and SMN2 genes, among others, which are key indicators of the disease. Priced at 7200 AED, this test provides a crucial early detection mechanism for families at risk, allowing for timely intervention and management of the condition. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures high accuracy and reliability, making it a valuable resource for affected individuals and their families.
The TSC1 and TSC2 Gene Analysis Test is a comprehensive genetic screening procedure aimed at identifying mutations in the TSC1 and TSC2 genes, which are known to cause tuberous sclerosis complex (TSC). TSC is a genetic disorder that can lead to the development of benign tumors in various parts of the body, including the brain, skin, heart, eyes, kidneys, and lungs. Early detection through this test can aid in the management and treatment of the condition, potentially improving the quality of life for those affected.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw, from the individual. The laboratory then uses advanced genetic sequencing techniques to analyze the TSC1 and TSC2 genes for any mutations that are associated with the disorder.
The cost of the TSC1 and TSC2 Gene Analysis Test at DNA Labs UAE is 7200 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in these specific genes. Given the potential impact on patient care and the complexity of the genetic analysis involved, this test represents a valuable tool for individuals at risk of tuberous sclerosis complex or those seeking a definitive diagnosis following the presentation of symptoms.
The "WS1 Full Gene Sequence Analysis Wolfram Syndrome (DIDMOAD) Test" is a sophisticated diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the WFS1 gene, which are indicative of Wolfram Syndrome. This rare, genetic disorder, also known as DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), presents a combination of symptoms affecting various organs and systems within the body. By analyzing the complete gene sequence, this test can provide crucial information for the accurate diagnosis of Wolfram Syndrome, enabling timely and appropriate management of the condition. The cost of the test is set at 7200 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. Through such detailed genetic testing, DNA Labs UAE plays a vital role in the early detection and treatment planning for individuals affected by this complex syndrome.
